Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 106–106 | Cite as

Dabrafenib/temozolomide/trametinib

Fatigue: case report
Case report
  • 8 Downloads

Reference

  1. Toll SA, et al. Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. Oncotarget 10: 551-557, No. 4, 2019. Available from: URL: http://doi.org/10.18632/oncotarget.26560 - USACrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations